Aurora Cannabis makes its long-awaited push into the U.S. with Reliva CBD acquisition
May 20, 2020 at 17:24 PM EDT
Over a year after Aurora Cannabis Inc. executives started publicly talking about making a push into the U.S. market, the company has made its move: the $40 million all-stock purchase of a cannabidiol maker called Reliva.
